Logo image of CNVS

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

NASDAQ:CNVS - Nasdaq - US1724063086 - Common Stock - Currency: USD

5.37  +0.05 (+0.94%)

Fundamental Rating

4

CNVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 73 industry peers in the Entertainment industry. CNVS has an average financial health and profitability rating. CNVS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CNVS was profitable.
In the past year CNVS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CNVS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CNVS reported negative operating cash flow in multiple years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.48%, CNVS is in the better half of the industry, outperforming 79.45% of the companies in the same industry.
CNVS's Return On Equity of 8.38% is fine compared to the rest of the industry. CNVS outperforms 76.71% of its industry peers.
CNVS has a better Return On Invested Capital (16.44%) than 91.78% of its industry peers.
Industry RankSector Rank
ROA 4.48%
ROE 8.38%
ROIC 16.44%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

The Profit Margin of CNVS (4.15%) is better than 75.34% of its industry peers.
CNVS's Profit Margin has improved in the last couple of years.
The Operating Margin of CNVS (10.14%) is better than 78.08% of its industry peers.
CNVS's Operating Margin has improved in the last couple of years.
CNVS has a Gross Margin of 50.40%. This is comparable to the rest of the industry: CNVS outperforms 57.53% of its industry peers.
In the last couple of years the Gross Margin of CNVS has declined.
Industry RankSector Rank
OM 10.14%
PM (TTM) 4.15%
GM 50.4%
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

5

2. Health

2.1 Basic Checks

CNVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CNVS has more shares outstanding
Compared to 5 years ago, CNVS has more shares outstanding
There is no outstanding debt for CNVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -6.74, we must say that CNVS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.74, CNVS is doing worse than 84.93% of the companies in the same industry.
There is no outstanding debt for CNVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -6.74
ROIC/WACC1.73
WACC9.48%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

CNVS has a Current Ratio of 1.11. This is a normal value and indicates that CNVS is financially healthy and should not expect problems in meeting its short term obligations.
CNVS has a Current ratio of 1.11. This is comparable to the rest of the industry: CNVS outperforms 57.53% of its industry peers.
CNVS has a Quick Ratio of 1.11. This is a normal value and indicates that CNVS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.11, CNVS is in line with its industry, outperforming 58.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 113.04% over the past year.
Measured over the past years, CNVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.06% on average per year.
CNVS shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.13%.
Measured over the past years, CNVS shows a quite strong growth in Revenue. The Revenue has been growing by 14.75% on average per year.
EPS 1Y (TTM)113.04%
EPS 3Y-3.06%
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)59.13%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%57.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-190.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 59.67 indicates a quite expensive valuation of CNVS.
CNVS's Price/Earnings ratio is a bit cheaper when compared to the industry. CNVS is cheaper than 69.86% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. CNVS is valued rather expensively when compared to this.
CNVS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 59.67
Fwd PE N/A
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

89.04% of the companies in the same industry are more expensive than CNVS, based on the Enterprise Value to EBITDA ratio.
95.89% of the companies in the same industry are more expensive than CNVS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5
EV/EBITDA 5.67
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CNVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEVERSE CORP

NASDAQ:CNVS (8/5/2025, 10:58:15 AM)

5.37

+0.05 (+0.94%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)06-27 2025-06-27/bmo
Earnings (Next)08-12 2025-08-12
Inst Owners14.91%
Inst Owner Change0.26%
Ins Owners12.8%
Ins Owner Change0.84%
Market Cap81.19M
Analysts82.5
Price Target8.67 (61.45%)
Short Float %3.59%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)80.79%
Min EPS beat(2)9.29%
Max EPS beat(2)152.29%
EPS beat(4)3
Avg EPS beat(4)34.3%
Min EPS beat(4)-50.83%
Max EPS beat(4)152.29%
EPS beat(8)5
Avg EPS beat(8)-31.84%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.33%
Min Revenue beat(2)6.87%
Max Revenue beat(2)9.79%
Revenue beat(4)3
Avg Revenue beat(4)4.24%
Min Revenue beat(4)-15.94%
Max Revenue beat(4)16.23%
Revenue beat(8)3
Avg Revenue beat(8)-2.16%
Revenue beat(12)6
Avg Revenue beat(12)4%
Revenue beat(16)9
Avg Revenue beat(16)7.37%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-30.43%
EPS NQ rev (3m)-30.43%
EPS NY rev (1m)11.11%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)-9.51%
Revenue NQ rev (3m)-9.51%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 59.67
Fwd PE N/A
P/S 1.04
P/FCF 5
P/OCF 4.66
P/B 2.1
P/tB 5.89
EV/EBITDA 5.67
EPS(TTM)0.09
EY1.68%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)1.07
FCFY20%
OCF(TTM)1.15
OCFY21.44%
SpS5.17
BVpS2.56
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.48%
ROE 8.38%
ROCE 20.81%
ROIC 16.44%
ROICexc 25.93%
ROICexgc N/A
OM 10.14%
PM (TTM) 4.15%
GM 50.4%
FCFM 20.77%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y117.54%
ROICexc growth 5YN/A
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
F-Score8
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 30.84%
Cap/Sales 1.5%
Interest Coverage 7.96
Cash Conversion 148.54%
Profit Quality 500.15%
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z -6.74
F-Score8
WACC9.48%
ROIC/WACC1.73
Cap/Depr(3y)30.78%
Cap/Depr(5y)28.81%
Cap/Sales(3y)1.85%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.04%
EPS 3Y-3.06%
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y-190.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)59.13%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%57.91%
Revenue Next Year-2.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y573.36%
EBIT growth 3Y93.13%
EBIT growth 5YN/A
EBIT Next Year86.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y239.27%
FCF growth 3Y56.46%
FCF growth 5Y20.06%
OCF growth 1Y264.38%
OCF growth 3Y52.8%
OCF growth 5Y17.54%